
Saturday, July 09, 2022 11:07:52 AM
Recent ITRM News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2025 09:00:32 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 07/18/2025 12:00:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/03/2025 08:16:04 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/03/2025 08:15:09 PM
- Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/02/2025 08:30:00 PM
- Iterum Names Christine Coyne as Chief Commercial Officer to Lead ORLYNVAH™ Launch and Commercial Growth • GlobeNewswire Inc. • 06/30/2025 11:00:00 AM
- Iterum Therapeutics Announces Publication of REASSURE Trial in NEJM Evidence • GlobeNewswire Inc. • 06/25/2025 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2025 11:15:25 AM
- Iterum Therapeutics Announces Partnership for Commercialization Services • GlobeNewswire Inc. • 06/11/2025 11:00:00 AM
- Iterum Therapeutics Announces Extension of Term of Promissory Note • GlobeNewswire Inc. • 05/19/2025 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 11:30:25 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2025 11:15:09 AM
- Iterum Therapeutics Reports First Quarter 2025 Financial Results • GlobeNewswire Inc. • 05/13/2025 11:00:00 AM
- Iterum Therapeutics to Report First Quarter 2025 Financial Results on May 13, 2025 • GlobeNewswire Inc. • 05/06/2025 11:00:00 AM
- Iterum Therapeutics Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares • GlobeNewswire Inc. • 04/30/2025 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2025 01:16:27 AM
- Iterum Therapeutics Announces $5 Million Registered Direct Offering of Ordinary Shares • GlobeNewswire Inc. • 04/29/2025 12:00:00 PM
- Iterum Therapeutics Presented a Scientific Poster at ECCMID 2025 Highlighting the Impact of Age on Antibiotic Resistance and Efficacy of Antibiotics • GlobeNewswire Inc. • 04/14/2025 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2025 12:00:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2025 12:35:07 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/20/2025 05:15:09 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2025 09:49:20 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/07/2025 09:33:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/07/2025 12:30:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2025 12:15:07 PM
A New Mining Model Built for Speed, Scale and Profit • AGI • Jul 17, 2025 9:00 AM
Rainmaker Announces Successful Deployment of Another Fully Containerized Seawater to Tap System in Turks and Caicos • RAKR • Jul 17, 2025 8:40 AM
Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies • FITY • Jul 17, 2025 8:30 AM
A New Mining Model Is Emerging - And Wall Street Is Paying Attention • B • Jul 15, 2025 9:00 AM
Sanwire Files Complaint Against Intercept Music and Trillium Partners • SNWR • Jul 15, 2025 9:00 AM
Cannabix Technologies Commences First Production of BreathLogix Alcohol Screening Devices • BLO • Jul 15, 2025 8:47 AM